Home
Conditions
Lymphoma, T-Cell, Cutaneous

Clinical trial condition

Lymphoma, T-Cell, Cutaneous

Explore clinical trials studying Lymphoma, T-Cell, Cutaneous. Study availability and eligibility vary by location and protocol.

389 public trials 42 recruiting studies

Refine in advanced search Browse all conditions

Lymphoma, T-Cell, Cutaneous trial results

Not yet recruiting

Aclarubicin Plus Cyclophosphamide, Vincristine, and Prednisone (CAOP) in Patients With Previously Treated Cutaneous T-cell Lymphoma

NCT07535710

Conditions: Cutaneous T Cell Lymphoma (CTCL), Cutaneous T-Cell Lymphoma Refractory, Cutaneous T-Cell Lymphoma, Relapsed, +16 more
Locations: Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai Shanghai, China

Ruijin Hospital Wuxi Branch Wuxi, China

View Trial Details

Not yet recruiting

A Phase 1, Multicenter, Open-label, Prospective, First-in-human Dose-escalation Clinical Trial of Domain Therapeutics' Anti-CCR8 Monoclonal Antibody (DT-7012) in Patients With Relapsed or Refractory Cutaneous T-cell Lymphomas (CTCL)

NCT07213882

Conditions: Cutaneous T Cell Lymphoma (CTCL), Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
Locations: Not specified

View Trial Details

Not yet recruiting

Brentuximab Vedotin in CutAneous T-cell Lymphomas (CTCL): Post-allogeneic Hematopoietic Stem Cell Transplant Maintenance

NCT07178457

Conditions: Brentuximab Vedotin, Cutaneous T Cell Lymphoma (CTCL), Hemic and Lymphatic Diseases, +10 more
Locations: Not specified

View Trial Details

Not yet recruiting

A Clinical Trial in Adults With Non-Hodgkin Lymphoma (NHL), With a Particular Emphasis on Cutaneous T Cell Lymphoma (CTCL), Testing the Safety and Activity of a Novel Drug to Inhibit a Protein Called Tumor Necrosis Factor Receptor 2 That Drives Both Lymphoma Growth and Escape of the Immune System

NCT06385522

Conditions: Cutaneous T Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
Locations: Not specified

View Trial Details

Not yet recruiting

Long-term Assessment of Chlormethine Gel in Mycosis Fungoides

NCT07046663

Conditions: Cutaneous T-Cell Lymphoma/Mycosis Fungoides, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
Locations: AOU Ospedali Riuniti - Clinica di Ematologia Ancona, Italy

SC Dermatologia, ASST-Papa Giovanni XXIII, Bergamo, Italy

UO Dermatologia - IRCCS Policlinico S.Orsola-Malpighi Bologna, Italy

UO Dermatologia ASST Spedali Civili Brescia Brescia, Italy

View all 20 locations

View Trial Details

Not yet recruiting

Evaluation of the KIR3DL2 Marker in Flow Cytometry for Sézary Syndrome Diagnosis, Therapeutic Response and Residual Disease: a Prospective and Multicenter Study

NCT06651203

Conditions: Cutaneous T Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
Locations: Not specified

View Trial Details

Not yet recruiting

TOtal Skin Electron Beam Therapy (Low-dose) for Tumor Clone Eradication in Early-stage Mycosis Fungoides

NCT05205902

Conditions: Cutaneous T Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
Locations: Not specified

View Trial Details

Not yet recruiting

Identification of Prognostic Factors and New Therapeutic Targets in Cutaneous Lymphomas

NCT04520529

Conditions: Cutaneous Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: Not specified

View Trial Details

Enrolling by invitation

Pilot Study to Characterize the Microbiome in Cutaneous T Cell Lymphoma Skin Lesions Before and After Use of CLn® Skin Care Body Wash

NCT06665490

Conditions: Cutaneous T Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: Northwestern University Department of Dermatology Chicago, Illinois, United States

View Trial Details

Active, not recruiting

Testing the Safety of the Anti-cancer Drugs Tazemetostat and Belinostat in Patients With Lymphomas That Have Resisted Treatment

NCT05627245

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +24 more
Locations: University of California Davis Comprehensive Cancer Center Sacramento, California, United States

Yale University New Haven, Connecticut, United States

University of Kansas Clinical Research Center Fairway, Kansas, United States

University of Kansas Cancer Center Kansas City, Kansas, United States

View Trial Details

Lymphoma, T-Cell, Cutaneous

Lymphoma, T-Cell, Cutaneous trial results

Related conditions